News tagged with novartis

Researchers decode the hamster genome

Genome researchers from Bielefeld University's Center for Biotechnology (CeBiTec) headed by Professor Dr. Alfred Pühler have succeeded in sequencing the genome of the Chinese hamster. The Chinese hamster ...

Aug 21, 2013
5 / 5 (3) 0 | with audio podcast

Nanosensors could aid drug manufacturing

MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs—especially those based on antibodies—more ...

Aug 16, 2013
5 / 5 (1) 1 | with audio podcast

Kryptonite for cancer cells

(Phys.org) —Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly ...

Mar 19, 2013
5 / 5 (5) 1

Study examines chemists' decision-making processes

(Phys.org)—Though we may not realize it, our minds spend a lot of time dis­carding infor­ma­tion. More like a big-​​box store than a box of choco­lates, life is con­stantly throwing us infor­ma­tion we don't ...

Jan 14, 2013
not rated yet 0

Continuous drug manufacturing offers speed, lower costs

Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into ...

Mar 12, 2012
5 / 5 (4) 0

UNICEF discloses vaccine prices for 1st time

UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.

May 29, 2011
5 / 5 (4) 1

New insights for a therapeutic approach in glioblastoma

(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research have identified a new and important molecular player in glioblastoma. The amount of the MNK1 kinase is not only dramatically ...

Mar 18, 2011
not rated yet 0

Chip-in-a-pill may be approved in 2012

(PhysOrg.com) -- Giant Swiss pharmaceutical company Novartis AG, based in Basel, is developing a pill containing an embedded microchip, which it hopes to submit for regulatory approval in Europe within 18 ...

Nov 10, 2010 report
4.9 / 5 (18) 10 | with audio podcast